FDA approves venetoclax for some CLL patients

FDA granted accelerated approval to Venclexta venetoclax (ABT-199, RG7601) from the Genentech Inc. unit of Roche (SIX:ROG;

Read the full 175 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE